<?xml version="1.0" encoding="UTF-8"?>
<p>Alphaviruses have been subjected to vector engineering procedures, including Semliki Forest virus (SFV), Sindbis virus (SIN) and Venezuelan equine encephalitis virus (VEE) [
 <xref rid="B173-biomedicines-08-00060" ref-type="bibr">173</xref>,
 <xref rid="B174-biomedicines-08-00060" ref-type="bibr">174</xref>,
 <xref rid="B175-biomedicines-08-00060" ref-type="bibr">175</xref>]. RNA replicons as well as recombinant alphavirus particles and DNA/RNA layered plasmids have been applied for cancer therapy. In one study, mice were immunized with SFV-LacZ RNA, which resulted in tumor regression [
 <xref rid="B58-biomedicines-08-00060" ref-type="bibr">58</xref>]. Since oncolytic alphaviruses occur naturally, they have been isolated and engineered from avirulent SFV strains. Using the SFV-VA7 avirulent strain, high infection rates and lysis of malignant cells were achieved, and solitary intravenous infusion prompted critical tumor relapse in a melanoma SCID mouse model [
 <xref rid="B60-biomedicines-08-00060" ref-type="bibr">60</xref>]. 
</p>
